Clinical Trials Directory

Trials / Terminated

TerminatedNCT05477485

Antiretroviral Improvement Among Medicaid Enrollees

Antiretroviral Improvement Among Medicaid Enrollees (AIMS): An Insurance-based Data to Care Initiative for Medicaid Enrollees in Virginia

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
19 Years – 64 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.

Detailed description

Virginia Commonwealth University and study collaborators are working together to learn about challenges that Virginia Medicaid members have in taking their prescribed medication. To do this, the researchers are implementing and evaluating a program called Antiretroviral Improvement among Medicaid enrolleeS (AIMS). This program is designed to support members to fill ART prescriptions. The program involves supporting Medicaid members with HIV directly by talking to them about challenges with filling their ART prescriptions and linking them to resources that can help with those challenges. Some members will be offered access to warm health technology support. The researchers think this support may increase how often ART prescriptions are filled and hope that the AIMS program can improve individuals' health and increase HIV viral suppression.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExperimental: AIMS program - patientPatient-level support will be offered to eligible Virginia Medicaid enrollees who have a late ART prescription refill(s) by \>30 days. Support will come from the provider, pharmacy, managed care organization or the community. Patient-level support will involve direct linkages and referrals for participants with a late ART prescription refill(s) \>30-60 days. Support will intensify as the gap in ART prescription(s) fills increases. For those with a late ART prescription refill(s) for \>60 days, added patient-level support will include warm health technology via PositiveLinks, a mobile app program promoting better health through self-monitoring tools, educational resources, direct messaging with program staff and a confidential user community board.
OTHERNo Intervention/Usual careParticipants in the usual care arm will receive standard state-level care for late ART prescription refill(s) for Virginia Medicaid enrollees living with HIV.

Timeline

Start date
2023-04-27
Primary completion
2024-05-31
Completion
2024-05-31
First posted
2022-07-28
Last updated
2025-10-21
Results posted
2025-10-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05477485. Inclusion in this directory is not an endorsement.

Antiretroviral Improvement Among Medicaid Enrollees (NCT05477485) · Clinical Trials Directory